NeuroOne's OneRF System Shows Promise in Treating Drug-Resistant Epilepsy
March 17, 2026 — NeuroOne's FDA-cleared OneRF Ablation System shows safe, effective treatment for drug-resistant epilepsy in peer-reviewed study, reducing seizures with real-time monitoring.